Cost-benefit analysis in occupational health: A comparison of intervention scenarios for occupational asthma and rhinitis among bakery workers

Occupational and Environmental Medicine

Volumn 68, Issue 10, 2011, Pages 739-745

  Meijster, Tim ^a   Van Duuren Stuurman, Birgit ^a   Heederik, Dick ^b   Houba, Remko ^c   Koningsveld, Ernst ^a   Warren, Nicholas ^d   Tielemans, Erik ^a  

^a TNO   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c Netherlands Expertise Center for Occupational Respiratory Disorders NECORD   (Netherlands)

^d HEALTH AND SAFETY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CONCEPTUAL FRAMEWORK; COST; COST BENEFIT ANALYSIS; DISEASE DURATION; DISEASE RELATED COST; EMPLOYER; FOOD INDUSTRY; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH SURVEY; HUMAN; INTERMETHOD COMPARISON; INTERVENTION COST; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MODEL; OCCUPATIONAL ASTHMA; OCCUPATIONAL HEALTH; OCCUPATIONAL MEDICINE; OPERATING COST; PRIORITY JOURNAL; PRODUCTIVITY; RHINITIS; SAFETY; SOCIETY; WORK DISABILITY; WORK ENVIRONMENT; WORKER;

ASTHMA; COST-BENEFIT ANALYSIS; HUMANS; MODELS, ECONOMIC; NETHERLANDS; OCCUPATIONAL DISEASES; OCCUPATIONAL HEALTH SERVICES; RHINITIS;

EID: 80052926778     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oem.2011.064709     Document Type: Article

References (39)

1. Veerman JL, Barendregt JJ, Mackenbach JP. Quantitative health impact assessment: current practice and future directions. J Epidemiol Community Health 2005;59:361-70. (Pubitemid 40559196)
2. Meijster T, Warren ND, Heederick D, et al. What is the best strategy to reduce the burden of occupational asthma and allergy in bakers? Occup Environ Med 2011;68:176-82.
3. Burdorf A. Economic evaluation in occupational health - its goals, challenges, and opportunities. Scand J Work Environ Health 2007;33:161-4. (Pubitemid 47019315)
4. Murray CJ, Evans DB, Acharya A, et al. Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ 2000;9:235-51. (Pubitemid 30248640)
5. Lahiri S, Gold J, Levenstein C. Net-cost model for workplace interventions. J Safety Res 2005;36:241-55. (Pubitemid 41042621)
6. Amador-Rodezno R. An overview to CERSSO's self evaluation of the cost-benefit on the investment in occupational safety and health in the textile factories: "a step by step methodology". J Safety Res 2005;36:215-29. (Pubitemid 41042618)
7. Koningsveld EA, Dul J, Van Rhijn GW, et al. Enhancing the impact of ergonomics interventions. Ergonomics 2005;48:559-80. (Pubitemid 40883645)
8. Oxenburgh M, Marlow P. The productivity assessment tool: computer-based cost benefit analysis model for the economic assessment of occupational health and safety interventions in the workplace. J Safety Res 2005;36:209-14. (Pubitemid 41042617)
9. Wild DM, Redlich CA, Paltiel AD. Surveillance for isocyanate asthma: a model based cost effectiveness analysis. Occup Environ Med 2005;62:743-9. (Pubitemid 41565008)
10. Lahiri S, Levenstein C, Nelson DI, et al. The cost effectiveness of occupational health interventions: prevention of silicosis. Am J Ind Med 2005;48:503-14. (Pubitemid 41746867)
11. Oostenbrink JB, Rutten-van Molken MP, Monz BU, et al. Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries. Value Health 2005;8:32-46. (Pubitemid 40293639)
12. Feenstra TL, Hamberg-van Reenen HH, Hoogenveen RT, et al. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study. Value Health 2005;8:178-90. (Pubitemid 41023477)
13. Warren N, Meijster T, Heederik D, et al. A dynamic population-based model for the development of work-related respiratory health effects among bakery workers. Occup Environ Med 2009;66:810-17.
14. Meijer E, Suarthana E, Rooijackers J, et al. Application of a prediction model for work-related sensitization in bakery workers. Eur Respir J 2010;36:735-42.
15. Driscoll T, Nelson DI, Steenland K, et al. The global burden of disease due to occupational carcinogens. Am J Ind Med 2005;48:419-31. (Pubitemid 41746860)
16. Driscoll T, Nelson DI, Steenland K, et al. The global burden of non-malignant respiratory disease due to occupational airborne exposures. Am J Ind Med 2005;48:432-45. (Pubitemid 41746861)
17. Koningsveld EA. Participation for understanding: an interactive method. J Safety Res 2005;36:231-6. (Pubitemid 41042619)
18. Hoogendoorn EJI, Feenstra TL, Rutten-van Molken MP. Inventarisatie van het gebruik en de kosten van zorg voor astma en COPD in Nederland [Resource Use and Costs of Care for Treating Asthma and COPD in the Netherlands](in Dutch). RIVM report no 260604001. Bilthoven, National Institute for Public Health and the Environment (RIVM), 2004.
19. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, et al. Handleiding voor kostenonderzoek, methoden en richtlijnprijzen voor economische evaluaties in de gezondheidszorg [Handbook for Cost Studies, Methods and Guidelines for Economic Evaluation in Health Care.] (updated version 2004, in Dutch). The Hague: Health Care Insurance Council, 2004.
20. Koopmanschap MA, Rutten FF, Van Ineveld BM, et al. The friction cost method for measuring indirect costs of disease. J Health Econ 1995;14:171-89.
21. Rachiotis G, Savani R, Brant A, et al. Outcome of occupational asthma after cessation of exposure: a systematic review. Thorax 2007;62:147-52.
22. Perfetti L, Cartier A, Ghezzo H, et al. Follow-up of occupational asthma after removal from or diminution of exposure to the responsible agent: relevance of the length of the interval from cessation of exposure. Chest 1998;114:398-403. (Pubitemid 28387514)
23. Vandenplas O, Toren K, Blanc PD. Health and socioeconomic impact of work-related asthma. Eur Respir J 2003;22:689-97. (Pubitemid 37258550)
24. Kok L, Hollanders D, Hop JP. Kosten en baten van reïntegratie [Costs and Benefits of Reintegration](in Dutch). Amsterdam: SEO economic research, 2006.
25. Blanc PD, Burney P, Janson C, et al. The prevalence and predictors of respiratory-related work limitation and occupational disability in an international study. Chest 2003;124:1153-9. (Pubitemid 37123341)
26. Eisner MD, Yelin EH, Katz PP, et al. Risk factors for work disability in severe adult asthma. Am J Med 2006;119:884-91. (Pubitemid 44415608)
27. Blanc PD, Cisternas M, Smith S, et al. Asthma, employment status, and disability among adults treated by pulmonary and allergy specialists. Chest 1996;109:688-96. (Pubitemid 26086935)
28. Ameille J, Pairon JC, Bayeux MC, et al. Consequences of occupational asthma on employment and financial status: a follow-up study. Eur Respir J 1997;10:55-8. (Pubitemid 27047180)
29. Meijster T, Tielemans E, Heederik DJ. Effect of an intervention aimed at reducing the risk of allergic respiratory disease in bakers: change in flour dust and fungal alpha-amylase levels. Occup Environ Med 2009;66:543-9.
30. Heijmans MJWM, Spreeuwenberg P, Rijken PM. Monitor zorg- en leefsituatie van mensen met astma en mensen met COPD; Trends en ontwikkelingen over de periode 2001-2004 (in Dutch). Utrecht: The Netherlands Institute for Health Services Research (NIVEL), 2005.
31. Van Dijk C, Verheij R, Schellevis F. Hooikoorts in de huisartsenpraktijk: kosten en verleende zorg [Hay fever in the general practitioners office: costs and provided care](in Dutch). Utrecht: The Netherlands Institute for Health Services Research (NIVEL), 2010.
32. Cisternas MG, Blanc PD, Yen IH, et al. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol 2003;111:1212-18. (Pubitemid 36683672)
33. Moscato G, Dellabianca A, Perfetti L, et al. Occupational asthma: a longitudinal study on the clinical and socioeconomic outcome after diagnosis. Chest 1999;115:249-56. (Pubitemid 29047083)
34. Ungar WJ, Coyte PC. Measuring productivity loss days in asthma patients. The Pharmacy Medication Monitoring Program and Advisory Board. Health Econ 2000;9:37-46.
35. Alexopoulos EC, Burdorf A. Prognostic factors for respiratory sickness absence and return to work among blue collar workers and office personnel. Occup Environ Med 2001;58:246-52. (Pubitemid 32240978)
36. Godard P, Chanez P, Siraudin L, et al. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J 2002;19:61-7. (Pubitemid 34105569)
37. Mellis CM, Peat JK, Bauman AE, et al. The cost of asthma in New South Wales. Med J Aust 1991;155:522-8.
38. Lamb CE, Ratner PH, Johnson CE, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin 2006;22:1203-10. (Pubitemid 44000740)
39. Malone DC, Lawson KA, Smith DH, et al. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99:22-7. (Pubitemid 27074893)